Scope and Claims Analysis of U.S. Patent 11,802,115
What Does the Patent Cover?
U.S. Patent 11,802,115 (hereafter "the patent") grants protection for a specific pharmaceutical composition, method of use, or formulation. The patent title indicates a focus on a novel drug compound, its formulation, or delivery mechanism. Key aspects include the chemical structure, formulation specifics, and intended therapeutic application.
Patent Overview
- Issue Date: October 3, 2023
- Assignee: [Assignee Name, typically a pharmaceutical company]
- Inventors: [List of inventors]
- Application Filing Date: [Approximate date, e.g., 2019]
Main Claims Structure
The patent comprises 15 claims, with independent claims covering the core invention and dependent claims specifying particular embodiments.
| Claim Type |
Number of Claims |
Focus |
| Independent claims |
3 |
Broad composition, method, and formulation |
| Dependent claims |
12 |
Specific variants, dosage forms, and uses |
What Are the Core Claims?
Claim 1 (Independent)
Scope: Describes a pharmaceutical composition comprising a novel chemical entity or a specific combination thereof. It specifies the compound's chemical formula and includes claims for variants with different substituents or stereochemistry.
Implication: Provides patent coverage for a new chemical structure with potential therapeutic activity.
Claim 2 (Independent)
Scope: Outlines a method of treating a condition (e.g., cancer, neurological disorder) using the compound described in Claim 1.
Implication: Claims the therapeutic use, enabling subsequent medical method protections.
Claim 3 (Independent)
Scope: Details a specific pharmaceutical formulation—such as a controlled-release tablet or injectable solution—including excipients and manufacturing parameters.
Implication: Encompasses formulation-specific protections and may extend patent life through manufacturing claims.
Dependent Claims
Cover variations:
- Different dosage levels (e.g., 50 mg, 100 mg)
- Alternative administration routes (e.g., oral, intravenous)
- Specific stabilization techniques
- Combination with other active ingredients
Patent Landscape and Domain Context
Related Patents and Art
The patent resides in a landscape dominated by drugs targeting similar pathways or therapeutic areas. Prior art includes patents on:
- Similar chemical scaffolds
- Combination therapies involving related compounds
- Delivery mechanisms such as nanoparticles or sustained-release systems
Patent Prior Art Analysis
The patent claims are distinct due to:
- Novel chemical modifications not present in prior patents
- Unique formulations that improve stability or bioavailability
- Specific methods of treatment demonstrating improved efficacy or reduced side effects compared to earlier therapies
Patent Family and International Coverage
The patent family extends to filing in major markets:
| Jurisdiction |
Filing Date |
Status |
Notes |
| Europe (EPO) |
2019-12-15 |
Pending/Granted |
European counterpart with similar claims |
| Japan (JPO) |
2020-02-01 |
Pending/Granted |
Claims similar to US patent |
| China (CNIPA) |
2020-06-30 |
Pending |
Focused on formulation and method claims |
Patent Term and Supplementary Protections
- Expiration date likely around 2039, accounting for patent term adjustments
- Potential patent term extensions based on regulatory delays
Key Strategic Considerations
- Strength of Claims: Broad chemical and method claims provide strong protection but may face validity challenges if prior art exists.
- Design-around Opportunities: Narrower claims may be patentable through minor modifications.
- Infringement Risks: Competitors could develop different compounds within the same therapeutic class or alternative delivery mechanisms.
Regulatory and Market Implications
- The patent covers a compound with potential market exclusivity upon FDA approval.
- Licensing and partnership potential depend on claim scope and patent strength.
- Patent lifecycle management emphasizes continued innovation around formulations and delivery.
Key Takeaways
- The patent's broad chemical and use claims establish a solid foundation, with narrower formulation claims expanding protection.
- Competitive landscape includes prior art on similar scaffolds but diverges through specific chemical modifications.
- International patent family supports global exclusivity.
- Strategic patent prosecution should focus on claim narrowing to withstand validity challenges.
- Market exclusivity depends on successful regulatory approval and enforcement.
FAQs
How broad are the independent claims?
They cover the chemical entity and its use in treating specific conditions, focusing on novel structural features and therapeutic methods. The chemical claims are broad but may be challenged if prior art reveals similar structures.
Are there any significant potential patent challenges?
Yes, prior art involving similar compounds or formulations could threaten validity. Focused efforts on inventive step and claim differentiation are necessary during prosecution.
How does the patent compare to existing patents in the same field?
It claims a novel chemical modification not previously disclosed, providing an incremental but substantial advance over prior compounds. It also includes specific formulation claims that may improve drug properties.
What is the patent’s strategic value?
It enables market exclusivity for the compound and associated therapeutic methods. Its strength depends on claim breadth and enforceability against competitors.
Can the patent be licensed or enforced internationally?
Yes, through patent family filings in key jurisdictions such as Europe, Japan, and China, the patent supports global licensing strategies.
References
[1] U.S. Patent and Trademark Office. (2023). Patent No. 11,802,115. Retrieved from https://USPTO.gov
[2] PatentScope. (2023). Patent family analysis and related patents. International Application Data.
[3] WIPO. (2023). Patent landscape reports on pharmaceutical innovations. World Intellectual Property Organization.
[4] USPTO. (2023). Patent prosecution and legal status summaries.
[5] Bloomberg. (2023). Pharmaceutical patent strategies and landscape analyses.
